Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 124022
Published online Nov 15, 2026. doi: 10.4251/wjgo.124022
Published online Nov 15, 2026. doi: 10.4251/wjgo.124022
Table 5 Univariate and multivariate Cox regression analysis of prognostic factors for progression-free survival and overall survival
| Variables | Subcategories | PFS-univariate analysis | PFS-multivariate analysis | OS-univariate analysis | OS-multivariate analysis | ||||
| P value | HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | ||
| Age | < 65 | ||||||||
| ≥ 65 | 0.128 | 1.414 (0.905-2.211) | 0.347 | 1.248 (0.787-1.981) | |||||
| Gender | Female | ||||||||
| Male | 0.489 | 1.175 (0.745-1.853) | 0.132 | 1.447 (0.895-2.339) | |||||
| ECOG | 0-1 | ||||||||
| 2 | 0.996 | 1.001 (0.640-1.567) | 0.524 | 0.856 (0.532-1.379) | |||||
| Primary tumor location | Right colon | ||||||||
| Left colon | < 0.001 | 0.456 (0.294-0.708) | < 0.001 | 0.385 (0.243-0.611) | 0.436 | 0.833 (0.525-1.320) | |||
| Primary tumor surgery | No | ||||||||
| Yes | 0.006 | 0.532 (0.341-0.831) | 0.023 | 0.591 (0.376-0.929) | 0.348 | 0.797 (0.496-1.281) | |||
| Histological type | Adenocarcinoma | ||||||||
| Mucinous adenocarcinoma | 0.193 | 1.454 (0.827-2.556) | 0.609 | 1.176 (0.632-2.187) | |||||
| Tumor differentiation | Poorly differentiated | ||||||||
| Moderately to well differentiated | 0.567 | 0.877 (0.560-1.374) | 0.751 | 1.083 (0.663-1.766) | |||||
| Lymphovascular perineural invasion | No | ||||||||
| Yes | 0.109 | 1.455 (0.920-2.302) | 0.011 | 1.819 (1.144-2.892) | 0.135 | 1.430 (0.894-2.286) | |||
| Liver metastasis | No | ||||||||
| Yes | 0.003 | 1.996 (1.260-3.164) | 0.012 | 1.830 (1.141-2.937) | < 0.001 | 3.772 (2.162-6.579) | < 0.001 | 3.516 (1.998-6.185) | |
| Lung metastasis | No | ||||||||
| Yes | 0.362 | 0.813 (0.521-1.268) | 0.087 | 0.668 (0.422-1.060) | |||||
| Number of metastatic organs | 1 | ||||||||
| ≥ 2 | 0.302 | 1.261 (0.812-1.959) | 0.849 | 1.046 (0.660-1.656) | |||||
| RAS | Unknown | ||||||||
| Wildtype | 0.388 | 1.313 (0.707-2.436) | 0.923 | 1.034 (0.528-2.024) | |||||
| Mutation | 0.134 | 1.566 (0.871-2.815) | 0.172 | 1.532 (0.831-2.826) | |||||
| Group | Control group | ||||||||
| Experimental group | 0.029 | 0.551 (0.323-0.939) | 0.020 | 0.509 (0.288-0.901) | 0.331 | 0.762 (0.441-1.317) | |||
- Citation: Zhang C, Wu SH, Jin L, Lu L, Li J, Jin S. Propensity score-based real-world study of immune checkpoint inhibitor combination therapy in microsatellite stable/proficient mismatch repair metastatic colorectal cancer. World J Gastrointest Oncol 2026; 18(11): 124022
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/124022.htm
- DOI: https://dx.doi.org/10.4251/wjgo.124022